BACKGROUND	Methods Subjects at 9 centers with Rutherford class 2 to 5 femoropopliteal lesions were randomized between June 2009 and December 2009 to treatment with Lutonix DCB ( n = 49 ) versus uncoated balloons ( control group [ n = 52 ] ) , stratified by whether balloon-only treatment ( n = 75 ) or stenting ( n = 26 ) was intended .\